SciELO - Scientific Electronic Library Online

vol.29 issue1Iodine nutrition and thyroid function assessment in childbearing age women from Queretaro, MexicoUse of a symbiotic supplement in a child with short bowel Syndrome: a case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Nutrición Hospitalaria

On-line version ISSN 1699-5198Print version ISSN 0212-1611


RODRIGUEZ LOPEZ, Mario et al. Biliopancreatic diversion and simultaneous resection of a giant ulcerated fatty mass in a patient with body mass index: 75. Nutr. Hosp. [online]. 2014, vol.29, n.1, pp.212-214. ISSN 1699-5198.

Bariatric Surgery is currently the best treatment option for patients with Morbid Obesity and a Body Mass Index ≥ 40 kg/m2. Despite its high rate of postoperative and nutritional complications, biliopancreatic diversion (Scopinaro s procedure) has shown best results in terms of excess weight loss and improving obesity-associated diseases. This technique was performed on a 52-year-old woman (weight = 174 Kg, height = 152 cm, BMI= 75.3 kg/m2), with a classic open access due to anaesthesiologist's indication. During this procedure it was also performed a resection of a giant fatty mass on the inner side of left lower limb, which was ulcerated and infected. Postoperative period was uneventful, excepting wound dehiscence of the leg, requiring resuturing. Six months after hospital discharge, the patient's percent excess weight loss was 36.98%. In our bariatric surgery series, with more than 400 patients since 2002, this patient was the one with the highest BMI.

Keywords : Morbid obesity; Body mass index; Bariatric surgery; Biliopancreatic diversion; Lipoma.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License